Gadolinium Deposition: What We Know and Don't Know, A Research Roadmap

to
Bethesda, MD

NIBIB organized a workshop at the National Institutes of Health (NIH), to explore concerns about the safety of gadolinium-based contrast agents (GBCAs) and gadolinium retention. The workshop was co-sponsored by NIH, the Radiological Society of North America (RSNA) and the American College of Radiology (ACR). 

Program Area
Meeting summaries and reports

The research roadmap resulting from this workshop identifies knowledge gaps about gadolinium retention and prioritizes directions for needed research.

Read the report here.

Citation: Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates. McDonald RJ, Levine D, Weinreb J, Kanal E, Davenport MS, Ellis JH, Jacobs PM, Lenkinski RE, Maravilla KR, Prince MR, Rowley HA, Tweedle MF, Kressel HY. Radiology, Sept. 11, 2018.

Read companion viewpoint in the Sept. 12, 2018, Journal of the American Medical Associtation here.

Presenter Slides

Session 2 - Gadolinium Speciation 

Discussion and Knowledge Gaps

Session 3 - Lanthanide and Gadolinium Toxicity

Discussion and Knowledge Gaps

Session 4 - Gadolinium/GBCA Deposition and Retention in the Brain 

Discussion and Knowledge Gaps

Session 5 - Gadolinium/GBCA Deposition and Retention in Other Organs  

Discussion and Knowledge Gaps

Session 6 - Clinical Manifestations of Gadolinium Retention 

Discussion and Knowledge Gaps

Session 7 - Big Data/Epidemiology 

Discussion and Knowledge Gaps